Literature DB >> 12574347

Antigen density presented by dendritic cells in vivo differentially affects the number and avidity of primary, memory, and recall CD8+ T cells.

Timothy N J Bullock1, David W Mullins, Victor H Engelhard.   

Abstract

We studied the size and avidity of primary and recall CD8(+) T cell responses in vivo in mice immunized with dendritic cells presenting different densities of a MHC class I-restricted peptide. Increasing the epitope density on a fixed number of dendritic cells increased the size of the primary response, yet had no influence on the avidity of the effector cells. However, epitope density-based selection of cells with different avidities was evident in the subsequent memory population, and in recall responses. Additionally, mice primed with different peptide densities had similarly sized quiescent memory and recall responses. Our findings provide evidence for an important role for epitope density in the selection of T cells in vivo.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12574347     DOI: 10.4049/jimmunol.170.4.1822

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  40 in total

1.  Kinetics of virus-specific CD8+ T cells and the control of human immunodeficiency virus infection.

Authors:  Miles P Davenport; Ruy M Ribeiro; Alan S Perelson
Journal:  J Virol       Date:  2004-09       Impact factor: 5.103

Review 2.  Early events governing memory CD8+ T-cell differentiation.

Authors:  Joshua J Obar; Leo Lefrançois
Journal:  Int Immunol       Date:  2010-05-26       Impact factor: 4.823

3.  Vaccination with High-Affinity Epitopes Impairs Antitumor Efficacy by Increasing PD-1 Expression on CD8+ T Cells.

Authors:  Christopher D Zahm; Viswa T Colluru; Douglas G McNeel
Journal:  Cancer Immunol Res       Date:  2017-06-20       Impact factor: 11.151

Review 4.  High-avidity CD8+ T cells: optimal soldiers in the war against viruses and tumors.

Authors:  Martha A Alexander-Miller
Journal:  Immunol Res       Date:  2005       Impact factor: 2.829

5.  Cutting edge: Dendritic cells prime a high avidity CTL response independent of the level of presented antigen.

Authors:  Charles J Kroger; Samuel Amoah; Martha A Alexander-Miller
Journal:  J Immunol       Date:  2008-05-01       Impact factor: 5.422

6.  Low Antigen Dose in Adjuvant-Based Vaccination Selectively Induces CD4 T Cells with Enhanced Functional Avidity and Protective Efficacy.

Authors:  Rolf Billeskov; Yichuan Wang; Shahram Solaymani-Mohammadi; Blake Frey; Shweta Kulkarni; Peter Andersen; Else Marie Agger; Yongjun Sui; Jay A Berzofsky
Journal:  J Immunol       Date:  2017-03-27       Impact factor: 5.422

Review 7.  Memory CD8+ T cell differentiation.

Authors:  Joshua J Obar; Leo Lefrançois
Journal:  Ann N Y Acad Sci       Date:  2010-01       Impact factor: 5.691

8.  Particle shape dependence of CD8+ T cell activation by artificial antigen presenting cells.

Authors:  Joel C Sunshine; Karlo Perica; Jonathan P Schneck; Jordan J Green
Journal:  Biomaterials       Date:  2013-10-05       Impact factor: 12.479

Review 9.  DC-based cancer vaccines.

Authors:  Eli Gilboa
Journal:  J Clin Invest       Date:  2007-05       Impact factor: 14.808

10.  Immunodominant West Nile Virus T Cell Epitopes Are Fewer in Number and Fashionably Late.

Authors:  Saghar Kaabinejadian; Curtis P McMurtrey; Sojung Kim; Rinki Jain; Wilfried Bardet; Fredda B Schafer; Jason L Davenport; Aaron D Martin; Michael S Diamond; Jon A Weidanz; Ted H Hansen; William H Hildebrand
Journal:  J Immunol       Date:  2016-04-20       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.